EYETECH PHARMACEUTICALS

Eyetech Pharmaceuticals is a biopharmaceutical company that specializes in novel therapeutics to treat diseases of the eye. The company conducted research and development into wet age-related macular degeneration diseases, which was seen as a breakthrough in the field. Valeant Pharmaceuticals International acquired Eyetech for US$22 million in 2012.
EYETECH PHARMACEUTICALS
Industry:
Biopharma Biotechnology Medical
Founded:
1997-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.eyetk.com
Total Employee:
251+
Status:
Closed
Total Funding:
108.5 M USD
Technology used in webpage:
SPF SAKURA Internet
Similar Organizations
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
JPMorgan Partners
JPMorgan Partners investment in Series C - Eyetech Pharmaceuticals
BB Biotech Ventures
BB Biotech Ventures investment in Series C - Eyetech Pharmaceuticals
Alta Partners
Alta Partners investment in Series C - Eyetech Pharmaceuticals
Schroder Ventures
Schroder Ventures investment in Series C - Eyetech Pharmaceuticals
Merrill Lynch
Merrill Lynch investment in Series C - Eyetech Pharmaceuticals
MPM Capital
MPM Capital investment in Series C - Eyetech Pharmaceuticals
Official Site Inspections
http://www.eyetk.com
- Host name: a67c48129651a0940.awsglobalaccelerator.com
- IP address: 76.223.67.189
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
